ADPT logo

Adaptive Biotechnologies (ADPT) EBIT

annual EBIT:

-$148.01M+$63.49M(+30.02%)
December 31, 2024

Summary

  • As of today (May 29, 2025), ADPT annual earnings before interest & taxes is -$148.01 million, with the most recent change of +$63.49 million (+30.02%) on December 31, 2024.
  • During the last 3 years, ADPT annual EBIT has risen by +$59.28 million (+28.60%).
  • ADPT annual EBIT is now -239.21% below its all-time high of -$43.63 million, reached on December 31, 2017.

Performance

ADPT EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherADPTincome statement metrics

quarterly EBIT:

-$26.93M+$3.84M(+12.48%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ADPT quarterly earnings before interest & taxes is -$26.93 million, with the most recent change of +$3.84 million (+12.48%) on March 31, 2025.
  • Over the past year, ADPT quarterly EBIT has increased by +$17.61 million (+39.55%).
  • ADPT quarterly EBIT is now -193.91% below its all-time high of -$9.16 million, reached on September 30, 2018.

Performance

ADPT quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherADPTincome statement metrics

TTM EBIT:

-$130.40M+$17.61M(+11.90%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ADPT TTM earnings before interest & taxes is -$130.40 million, with the most recent change of +$17.61 million (+11.90%) on March 31, 2025.
  • Over the past year, ADPT TTM EBIT has increased by +$71.47 million (+35.41%).
  • ADPT TTM EBIT is now -892.54% below its all-time high of -$13.14 million, reached on March 31, 2018.

Performance

ADPT TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherADPTincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

ADPT EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+30.0%+39.5%+35.4%
3 y3 years+28.6%+57.1%+43.3%
5 y5 years-88.8%+22.2%-40.3%

ADPT EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+30.0%at high+59.5%at high+43.9%
5 y5-year-88.8%+30.0%at high+59.5%-40.3%+43.9%
alltimeall time-239.2%+30.0%-193.9%+59.5%-892.5%+43.9%

ADPT EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
-$26.93M(-12.5%)
-$130.40M(-11.9%)
Dec 2024
-$148.01M(-30.0%)
-$30.77M(+5.5%)
-$148.01M(-19.4%)
Sep 2024
-
-$29.16M(-33.1%)
-$183.71M(-8.7%)
Jun 2024
-
-$43.55M(-2.2%)
-$201.22M(-0.3%)
Mar 2024
-
-$44.54M(-33.0%)
-$201.88M(-4.6%)
Dec 2023
-$211.50M(+7.8%)
-$66.45M(+42.4%)
-$211.50M(+16.4%)
Sep 2023
-
-$46.67M(+5.6%)
-$181.63M(+1.1%)
Jun 2023
-
-$44.21M(-18.4%)
-$179.63M(-4.2%)
Mar 2023
-
-$54.17M(+48.1%)
-$187.50M(-4.4%)
Dec 2022
-$196.13M(-5.4%)
-$36.58M(-18.1%)
-$196.13M(-11.2%)
Sep 2022
-
-$44.67M(-14.2%)
-$220.90M(-4.9%)
Jun 2022
-
-$52.08M(-17.1%)
-$232.24M(+1.0%)
Mar 2022
-
-$62.80M(+2.3%)
-$229.92M(+10.3%)
Dec 2021
-$207.30M
-$61.36M(+9.6%)
-$208.40M(+8.9%)
Sep 2021
-
-$56.00M(+12.5%)
-$191.28M(+11.0%)
DateAnnualQuarterlyTTM
Jun 2021
-
-$49.77M(+20.6%)
-$172.33M(+8.1%)
Mar 2021
-
-$41.28M(-6.7%)
-$159.48M(+4.4%)
Dec 2020
-$152.82M(+94.9%)
-$44.24M(+19.4%)
-$152.82M(+15.1%)
Sep 2020
-
-$37.05M(+0.4%)
-$132.77M(+16.7%)
Jun 2020
-
-$36.91M(+6.6%)
-$113.77M(+22.4%)
Mar 2020
-
-$34.62M(+43.1%)
-$92.97M(+18.6%)
Dec 2019
-$78.39M(+57.6%)
-$24.19M(+34.0%)
-$78.39M(+14.7%)
Sep 2019
-
-$18.05M(+12.1%)
-$68.35M(+15.0%)
Jun 2019
-
-$16.11M(-19.7%)
-$59.45M(+4.9%)
Mar 2019
-
-$20.05M(+41.7%)
-$56.66M(+13.9%)
Dec 2018
-$49.76M(+14.0%)
-$14.14M(+54.4%)
-$49.76M(+39.7%)
Sep 2018
-
-$9.16M(-31.2%)
-$35.61M(+34.6%)
Jun 2018
-
-$13.31M(+1.3%)
-$26.45M(+101.3%)
Mar 2018
-
-$13.14M
-$13.14M
Dec 2017
-$43.63M
-
-

FAQ

  • What is Adaptive Biotechnologies annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Adaptive Biotechnologies?
  • What is Adaptive Biotechnologies annual EBIT year-on-year change?
  • What is Adaptive Biotechnologies quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Adaptive Biotechnologies?
  • What is Adaptive Biotechnologies quarterly EBIT year-on-year change?
  • What is Adaptive Biotechnologies TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Adaptive Biotechnologies?
  • What is Adaptive Biotechnologies TTM EBIT year-on-year change?

What is Adaptive Biotechnologies annual earnings before interest & taxes?

The current annual EBIT of ADPT is -$148.01M

What is the all time high annual EBIT for Adaptive Biotechnologies?

Adaptive Biotechnologies all-time high annual earnings before interest & taxes is -$43.63M

What is Adaptive Biotechnologies annual EBIT year-on-year change?

Over the past year, ADPT annual earnings before interest & taxes has changed by +$63.49M (+30.02%)

What is Adaptive Biotechnologies quarterly earnings before interest & taxes?

The current quarterly EBIT of ADPT is -$26.93M

What is the all time high quarterly EBIT for Adaptive Biotechnologies?

Adaptive Biotechnologies all-time high quarterly earnings before interest & taxes is -$9.16M

What is Adaptive Biotechnologies quarterly EBIT year-on-year change?

Over the past year, ADPT quarterly earnings before interest & taxes has changed by +$17.61M (+39.55%)

What is Adaptive Biotechnologies TTM earnings before interest & taxes?

The current TTM EBIT of ADPT is -$130.40M

What is the all time high TTM EBIT for Adaptive Biotechnologies?

Adaptive Biotechnologies all-time high TTM earnings before interest & taxes is -$13.14M

What is Adaptive Biotechnologies TTM EBIT year-on-year change?

Over the past year, ADPT TTM earnings before interest & taxes has changed by +$71.47M (+35.41%)
On this page